Name:	egrx_BusinessCombinationConsiderationTransferredIncludingContingentConsiderationArrangementsRangeofOutcomesHigh
Namespace Prefix:	egrx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Business Combination, Contingent Consideration Arrangements, Lump Sum Milestone Payment

No definition available.

Name:	egrx_BusinessCombinationContingentConsiderationArrangementsLumpSumMilestonePayment
Namespace Prefix:	egrx_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Business Combination, Contingent Consideration, Liability, Number of Separate Milestone Payments

No definition available.

Name:	egrx_BusinessCombinationContingentConsiderationLiabilityNumberofSeparateMilestonePayments
Namespace Prefix:	egrx_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

Clinical Development Cost Sharing Percentage

No definition available.

Name:	egrx_ClinicalDevelopmentCostSharingPercentage
Namespace Prefix:	egrx_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	instant

License Agreement, Potential Milestone Payments

No definition available.

Name:	egrx_LicenseAgreementPotentialMilestonePayments
Namespace Prefix:	egrx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

License Agreement, Proceeds From Upfront Payment

No definition available.

Name:	egrx_LicenseAgreementProceedsFromUpfrontPayment
Namespace Prefix:	egrx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

Licensing Agreement, Milestone Proceeds

No definition available.

Name:	egrx_LicensingAgreementMilestoneProceeds
Namespace Prefix:	egrx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

Licensing Agreement, Proceeds From Unique Billing Code

No definition available.

Name:	egrx_LicensingAgreementProceedsFromUniqueBillingCode
Namespace Prefix:	egrx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

Maximum Expected Cash Proceeds On Additional Milestones

No definition available.

Name:	egrx_MaximumExpectedCashProceedsOnAdditionalMilestones
Namespace Prefix:	egrx_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

Number Of People Treated For Accidental Exposure to Organophosphate Pesticides Yearly

No definition available.

Name:	egrx_NumberOfPeopleTreatedForAccidentalExposuretoOrganophosphatePesticidesYearly
Namespace Prefix:	egrx_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

Number Of Products

No definition available.

Name:	egrx_NumberOfProducts
Namespace Prefix:	egrx_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

Royalty Revenue, Percent Of Net Sales Threshold

No definition available.

Name:	egrx_RoyaltyRevenuePercentOfNetSalesThreshold
Namespace Prefix:	egrx_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

Royalty Revenue, Percentage of Net Sales

No definition available.

Name:	egrx_RoyaltyRevenuePercentageofNetSales
Namespace Prefix:	egrx_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

Number of shares of equity interests issued or issuable to acquire entity.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (b)(4)
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479

Name:	us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 30
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 30
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477

Name:	us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (c)(3)
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479

Name:	us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

Percentage points added to the reference rate to compute the variable rate on the debt instrument.

No definition available.

Name:	us-gaap_DebtInstrumentBasisSpreadOnVariableRate1
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

No definition available.

Name:	us-gaap_DebtInstrumentTerm
Namespace Prefix:	us-gaap_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.

No definition available.

Name:	us-gaap_LineOfCreditFacilityCommitmentFeePercentage
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(b),22(b))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Name:	us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.

No definition available.

Name:	us-gaap_NumberOfReportableSegments
Namespace Prefix:	us-gaap_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	duration

The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (b)(1)
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585

Name:	us-gaap_PaymentsToAcquireBusinessesGross
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Cash received from licensees for license fees during the current period.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3536-108585

Name:	us-gaap_ProceedsFromLicenseFeesReceived
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3255-108585

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(f))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Name:	us-gaap_ProceedsFromLinesOfCredit
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

Amount of stock repurchase plan authorized.

No definition available.

Name:	us-gaap_StockRepurchaseProgramAuthorizedAmount1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

No definition available.

Name:	us-gaap_SubsidiarySaleOfStockLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

Number of shares that have been repurchased during the period and are being held in treasury.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Name:	us-gaap_TreasuryStockSharesAcquired
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 30
-Section 45
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Name:	us-gaap_TreasuryStockValueAcquiredCostMethod
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

Name:	srt_MajorCustomersAxis=egrx_TevaPharmaceuticalsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	srt_MajorCustomersAxis=egrx_CephalonInc.Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_BusinessAcquisitionAxis=egrx_EagleBiologicsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_ContingentConsiderationByTypeAxis=egrx_MilestonePaymentsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_DebtInstrumentAxis=egrx_AmendmentCreditAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	srt_RangeAxis=srt_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	srt_RangeAxis=srt_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_CreditFacilityAxis=us-gaap_LineOfCreditMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_VariableRateAxis=us-gaap_PrimeRateMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_ShareRepurchaseProgramAxis=egrx_October2018PlanMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_ShareRepurchaseProgramAxis=egrx_AcceleratedShareRepurchaseMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Name:	us-gaap_ShareRepurchaseProgramAxis=egrx_AdditionalSharesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: